However, the PR-BC-exo with gp96-deficiency did not influence paclitaxel-resistance in PS-BC cells (Figures 3E–G and Figures S4A, B), suggesting that PR-BC-exo transmitted gp96 to increase paclitaxel-resistance in PS-BC cells. Here, HSP90B1 is linked to breast cancer.